Home | Publications | Diagnostics place holder
place holder place holder

Diagnostics

B·R·A·H·M·S Aktiengesellschaft Product Pipeline Analysis


Publication Date   May 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   21
ISBN Number   not applicable
Product Code   GMD571
Ask a question about this product?

Price £505.00

approximately: $750 | €594

Summary


This report is an insightful source for data, analysis and strategic insights into a BRAHMS Aktiengesellschaft's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reason to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Company Overview
    • 2.1 Key Information
    • 2.2 Financial Performance
    • 2.3 Industry Outlook - In Vitro Diagnostics
  • 3 BRAHMS Aktiengesellschaft Pipeline Products
    • 3.1 BRAHMS Aktiengesellschaft Product Pipeline Analysis
      • 3.1.1 BRAHMS Aktiengesellschaft Pipeline Products By Equipment Type
      • 3.1.2 BRAHMS Aktiengesellschaft Pipeline Products By Development Stage
      • 3.1.3 BRAHMS Aktiengesellschaft Pipeline Products By Therapy Area
      • 3.1.4 BRAHMS Aktiengesellschaft Pipeline Products By Clinical Trials
    • 3.2 BRAHMS TRAK KRYPTOR
      • 3.2.1 Product Description
      • 3.2.2 Product Status
    • 3.3 MR-proANP biomarker
      • 3.3.1 Product Description
      • 3.3.2 Product Status
    • 3.4 MR-proADM biomarker
      • 3.4.1 Product Description
      • 3.4.2 Product Status
      • 3.4.3 Clinical Trials
    • 3.5 CT-proAVP biomarker
      • 3.5.1 Product Description
      • 3.5.2 Product Status
    • 3.6 CT-proET-1 biomarker
      • 3.6.1 Product Description
      • 3.6.2 Product Status
      • 3.6.3 Clinical Trials
  • 4 Major Products and Services
    • 4.1 Overview
  • 5 Competitors
  • 6 Key Employees
  • 7 Locations And Subsidiaries
    • 7.1 Head Office
    • 7.2 Other Locations & Subsidiaries
  • 8 Appendix
    • 8.1 Methodology
      • 8.1.1 Coverage
      • 8.1.2 Secondary Research
      • 8.1.3 Primary Research
      • 8.1.4 Expert Panel Validation
    • 8.2 Contact Us
    • 8.3 About Global Markets Direct
    • 8.4 Disclaimer
  • List of Tables
    • Table 1: BRAHMS Aktiengesellschaft,Key Facts
    • Table 2: BRAHMS Aktiengesellschaft Pipeline Products by Equipment Type
    • Table 3: BRAHMS Aktiengesellschaft Pipeline Products By Development Stage
    • Table 4: BRAHMS Aktiengesellschaft Pipeline Products By Therapy Area
    • Table 5: BRAHMS Aktiengesellschaft Pipeline Products By Clinical Trials
    • Table 6: BRAHMS Aktiengesellschaft, Key Employees,
    • Table 7: BRAHMS Aktiengesellschaft, Other Locations
    • Table 8: BRAHMS Aktiengesellschaft, Subsidiaries
  • List of Figures
    • Figure 1: Global Markets Direct Methodology